Tweets
NEJM Clinical Images - Tongue Necrosis in Giant Cell Arteritis. 74-yoF w/ 3-day hx of HA and tongue swelling/pain, & blindness in the right eye. Tongue was ulcerated, R temporal artery thickened. ESR 42 CRP 169 mg/L. Read rest of story... https://t.co/Npc48trzk6 https://t.co/YfikSZmjWk
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
Might Tofacitinib Reduce Malignancy Risk with Patients with RA?
https://t.co/lrBwN6meQR https://t.co/cW2FEGbEaH
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
Cochrane analysis of NSAIDs in acute #Gout - 28 trials, 3406 pts showed:
- NSAIDs > PBO 50% pain reduction @24hrs, but = to PBO for AEs & W/D
- nonselective NSAIDs = COX-2 inhib, but former has more AE & WD
- PRED - NSAIDS, but pred has more AE & WD
https://t.co/AemfID4RLN https://t.co/Ex1stFG9WG
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
JAK Safety -- The Lowdown on Infection: Drs. Kevin Winthrop and Jonathan Kay
https://t.co/6Um0la1yRi https://t.co/W4xHBxB2AV
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-Related Arthritis (ERA)- Current Challenges and Future Outlook
https://t.co/O6GENGGxKm
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
Study of 408 men with inflammatory arthritis fathered 897 singleton pregnancies with 794 live births. Pregnancies conceived after the diagnosis of IA had higher rate of miscarriage (12.3 vs 7.5%, p = <0.05), even after adjusting for confounders (OR 2.03) https://t.co/Nq2lP0SXTL
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
BMS announced today that Orencia as 1st FDA approved drug to prevent acute graft versus host disease & may be used in bone marrow or stem cell transplantation from an unrelated donor. (Based on 186 pt RCT w/ Orencia showing better survival (98 vs 75% PBO) https://t.co/9j9fPEwKJU
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
New podcast up!
Drs. Jack Cush and Martin Bergman review the topic of treat-to-target (T2T) management in rheumatology.
Both will debate the pro's and con's of the T2T strategy at the upcoming RWCS meeting on Feb. 17, 2022.
https://t.co/TBX2RvCCB6 https://t.co/LYBoViqmpD
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
Reproductive Health in Rheumatic Diseases: Drs. Bermas, Buyon and Dao
https://t.co/mnRwCOGYXp https://t.co/j8xSm60jLr
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
Increased risk death in 310 scleroderma pts: 63 diffuse SSc, 279 limited dz & 33 sine scleroderma (SMR = 1.88). Reduced survival at 10 yrs (78%) & 15 yrs(61%). 69 deaths, 46% in diffuse PSS - due to ILD, PHA, and GI involvement https://t.co/w300etSls2
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
NYC Hosp for Special Surgery is the 1st to use a "smart" knee arthroplasty - TKR with a smart sensor capable of monitoring steps, speed, range of motion & other knee functions fed back to the orthopedist = called Persona IQ, FDA authorized https://t.co/QR49JC7oCz
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
Pre-clinical RA: starting off the wrong foot
https://t.co/LA2dLaAM6C https://t.co/lgKFY0zDeq
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
